29 Facts About Ken Alibek

In 1994, Ken Alibek received a congressional award, a bronze Barkley medal awarded in recognition of distinguished public service and his contribution to world peace.

In 2002, Ken Alibek told United Press International that there is concern that monkeypox could be engineered into a biological weapon.

Ken Alibek grew up in Almaty, the republic's former capital.

Ken Alibek is a certified oncologist, a doctor of science, doctor of philosophy and a doctor of medicine.

At Omutninsk, Ken Alibek mastered the art and science of formulating and evaluating nutrient media and cultivation conditions for the optimization of microbial growth.

Ken Alibek was transferred to the Kazakhstan Scientific and Production Base in Stepnogorsk to become the new director of that facility.

At Stepnogorsk, Ken Alibek created an efficient industrial scale assembly line for biological formulations.

In Moscow, Ken Alibek began his service as deputy chief of the biosafety directorate at Biopreparat.

Ken Alibek was promoted in 1988 to first deputy director of Biopreparat, where he not only oversaw the biological weapons facilities but the significant number of pharmaceutical facilities that produced antibiotics, vaccines, sera, and interferon for the public.

Gorbachev approved the proposal, but an additional paragraph was secretly inserted into Ken Alibek's draft, resulting in a presidential decree that ordered the end of Biopreparat's biological weapons work but required them to remain prepared for future bioweapons production.

Ken Alibek used his position at Biopreparat and the authority granted to him by the first part of the decree to begin the destruction of the biological weapons to dismantle biological weapons production and testing capabilities at a number of research and development facilities, including Stepnogorsk, Kol'tsovo, Obolensk, and others.

Ken Alibek negotiated a concurrent appointment to a Biopreparat facility called Biomash.

In January 1992, not long after his return from the US, Ken Alibek protested against Russia's continuation of bioweapons work and resigned from both the Russian Army and Biopreparat.

Ken Alibek was the impetus behind the creation of a biodefense graduate program at the Schar School of Policy and Government at George Mason University, serving as Distinguished Professor of Medical Microbiology and the program's Director of Education.

Ken Alibek developed the plans for the university's biosafety level three research facility and secured $40 million of grants from the federal and state governments for its construction.

In 1999, Ken Alibek published an autobiographical account of his work in the Soviet Union and his defection.

Ken Alibek was president, chief scientific officer, and chief executive officer at AFG Biosolutions, Inc in Gaithersburg, Maryland, where he and his scientific team continued their development of advanced solutions for antimicrobial immunity.

Ken Alibek created a new pharmaceutical production company, MaxWell Biocorporation, in 2006 and served as its chief executive officer and president.

Ken Alibek focuses on the role of chronic viral and bacterial infections in causing age-related diseases and premature aging.

In 2010, Ken Alibek was invited to begin working in Kazakhstan as a head of the Department of Chemistry and Biology at the School of Science and Technology of Nazarbayev University in Astana, where he was engaged in the development of anti-cancer drugs and life-prolonging drugs, and was chairman of the board of the Republican Scientific Center for Emergency Medical Care and headed the National Scientific Center for Oncology and Transplantation.

Ken Alibek focused on a possible role of chronic infections, metabolic disorders, and immunosuppression on cancer development.

Ken Alibek continues his work as an administrative manager of a research and medicine and education professor.

In 2016, Ken Alibek was chosen as one of the nominees in the "Science" category of the national project El Tulgasy, which was designed to select the most significant citizens of Kazakhstan who are associated with national achievements.

In January 2020, Ken Alibek issued a warning about COVID-19 and its potential as a global problem.

Ken Alibek wrote two chapters on methods to protect against the COVID-19 pandemic in the book Defending Against Biothreats: What We Can Learn from the Coronavirus Pandemic to Enhance US Defenses Against Pandemics and Biological Weapons.

In 2021, Ken Alibek offered a free seminar on the antiviral biodefence in the world of epidemic uncertainties.

Ken Alibek's patients are located predominantly in nations in the former Soviet Union and Ukraine, and he consults mainly using free telemedicine services.

Ken Alibek has published 6 studies in peer-reviewed journals about the causes and treatment of Autism, and has one issued US patent and three US patent filings on his novel approach to treatment.

Ken Alibek has a wife and five children ; one of his daughters is autistic.